A detailed history of Sei Investments CO transactions in Castle Biosciences Inc stock. As of the latest transaction made, Sei Investments CO holds 37,874 shares of CSTL stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,874
Holding current value
$1.06 Million
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.4 - $31.47 $659,007 - $1.19 Million
37,874 New
37,874 $1.08 Million
Q2 2023

Aug 11, 2023

BUY
$11.66 - $26.0 $159,368 - $355,368
13,668 Added 14.19%
109,995 $1.51 Million
Q1 2023

May 12, 2023

BUY
$19.47 - $28.49 $1.88 Million - $2.74 Million
96,327 New
96,327 $2.19 Million
Q3 2022

Nov 14, 2022

SELL
$22.51 - $34.32 $399,755 - $609,488
-17,759 Reduced 16.69%
88,625 $2.31 Million
Q2 2022

Aug 15, 2022

BUY
$16.0 - $45.99 $1.7 Million - $4.89 Million
106,384 New
106,384 $2.34 Million
Q4 2021

Feb 14, 2022

SELL
$39.06 - $67.58 $366,148 - $633,494
-9,374 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$60.13 - $77.6 $100,717 - $129,979
-1,675 Reduced 15.16%
9,374 $624,000
Q2 2021

Aug 06, 2021

SELL
$50.07 - $76.78 $42,659 - $65,416
-852 Reduced 7.16%
11,049 $838,000
Q1 2021

May 12, 2021

BUY
$58.92 - $97.33 $188,720 - $311,747
3,203 Added 36.82%
11,901 $816,000
Q4 2020

Feb 08, 2021

SELL
$43.6 - $73.05 $365,062 - $611,647
-8,373 Reduced 49.05%
8,698 $588,000
Q3 2020

Dec 04, 2020

SELL
$38.47 - $52.03 $64,052 - $86,629
-1,665 Reduced 8.89%
17,071 $879,000
Q3 2020

Nov 06, 2020

BUY
$38.47 - $52.03 $225,588 - $305,103
5,864 Added 45.56%
18,736 $965,000
Q2 2020

Aug 11, 2020

SELL
$27.28 - $43.01 $100,772 - $158,878
-3,694 Reduced 22.3%
12,872 $485,000
Q1 2020

May 14, 2020

BUY
$23.08 - $35.53 $199,803 - $307,583
8,657 Added 109.46%
16,566 $494,000
Q4 2019

Feb 06, 2020

BUY
$15.74 - $35.04 $124,487 - $277,131
7,909 New
7,909 $272,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $739M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.